Eurazeo Total Liabilities
Eurazeo total liabilities. Based on the latest financial reports, Eurazeo (RF) has total liabilities worth €1.97 Billion EUR (≈ $2.31 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RF asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Eurazeo (2003–2025)
Total liabilities of Eurazeo from 2003 to 2025. This chart illustrates how Eurazeo's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Eurazeo to see how much of total assets are deployed in long-term investments.
Eurazeo Competitors by Total Liabilities
The table below lists competitors of Eurazeo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aya Gold & Silver Inc
TO:AYA
|
Canada | CA$201.38 Million |
|
Alliance Resource Partners LP
NASDAQ:ARLP
|
USA | $1.16 Billion |
|
Nien Made Enterprise Co Ltd
TW:8464
|
Taiwan | NT$10.05 Billion |
|
Lepu Medical Tech Beijing
SHE:300003
|
China | CN¥7.61 Billion |
|
MERCARI INC. UNSP.ADR/1/2
F:6TP0
|
Germany | €503.91 Billion |
|
Community Bank System Inc
NYSE:CBU
|
USA | $15.72 Billion |
|
Freshworks Inc
NASDAQ:FRSH
|
USA | $594.52 Million |
|
Wendel
PA:MF
|
France | €10.31 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Eurazeo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Eurazeo (RF) total assets.
Liquidity & Leverage Metrics
Eurazeo Total Liabilities Ratios Explained
Eurazeo total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurazeo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurazeo (2003–2025)
The table below shows the annual total liabilities of Eurazeo from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.70 Billion ≈ $1.98 Billion |
-9.32% |
| 2024-12-31 | €1.87 Billion ≈ $2.19 Billion |
+32.47% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
-85.25% |
| 2022-12-31 | €9.57 Billion ≈ $11.19 Billion |
+20.69% |
| 2021-12-31 | €7.93 Billion ≈ $9.27 Billion |
+2.65% |
| 2020-12-31 | €7.73 Billion ≈ $9.04 Billion |
+6.07% |
| 2019-12-31 | €7.29 Billion ≈ $8.52 Billion |
+24.68% |
| 2018-12-31 | €5.84 Billion ≈ $6.83 Billion |
+4.92% |
| 2017-12-31 | €5.57 Billion ≈ $6.51 Billion |
+8.27% |
| 2016-12-31 | €5.14 Billion ≈ $6.01 Billion |
+95.79% |
| 2015-12-31 | €2.63 Billion ≈ $3.07 Billion |
-70.10% |
| 2014-12-31 | €8.79 Billion ≈ $10.27 Billion |
-0.46% |
| 2013-12-31 | €8.83 Billion ≈ $10.32 Billion |
-13.50% |
| 2012-12-31 | €10.21 Billion ≈ $11.93 Billion |
-4.44% |
| 2011-12-31 | €10.68 Billion ≈ $12.49 Billion |
+4.41% |
| 2010-12-31 | €10.23 Billion ≈ $11.96 Billion |
-5.20% |
| 2009-12-31 | €10.79 Billion ≈ $12.62 Billion |
-3.47% |
| 2008-12-31 | €11.18 Billion ≈ $13.07 Billion |
+3.07% |
| 2007-12-31 | €10.85 Billion ≈ $12.68 Billion |
+2204.45% |
| 2003-12-31 | €470.68 Million ≈ $550.27 Million |
-- |
About Eurazeo
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, … Read more